Cargando…
Sialyltransferase Inhibitors for the Treatment of Cancer Metastasis: Current Challenges and Future Perspectives
Potent, cell-permeable, and subtype-selective sialyltransferase inhibitors represent an attractive family of substances that can potentially be used for the clinical treatment of cancer metastasis. These substances operate by specifically inhibiting sialyltransferase-mediated hypersialylation of cel...
Autores principales: | Perez, Ser John Lynon P., Fu, Chih-Wei, Li, Wen-Shan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8470674/ https://www.ncbi.nlm.nih.gov/pubmed/34577144 http://dx.doi.org/10.3390/molecules26185673 |
Ejemplares similares
-
Sialidase and Sialyltransferase Inhibitors: Targeting Pathogenicity and Disease
por: Bowles, William H. D., et al.
Publicado: (2021) -
Marine Bacterial Sialyltransferases
por: Yamamoto, Takeshi
Publicado: (2010) -
Sialyltransferases and Neuraminidases: Potential Targets for Cancer Treatment
por: Nag, Sagorika, et al.
Publicado: (2022) -
A New Assay for Determining Ganglioside Sialyltransferase Activities Lactosylceramide-2,3-Sialyltransferase (SAT I) and Monosialylganglioside-2,3-Sialyltransferase (SAT IV)
por: Sun, Cynthia Q., et al.
Publicado: (2014) -
Unique gangliosides synthesized in vitro by sialyltransferases from
marine bacteria and their characterization: ganglioside synthesis by bacterial
sialyltransferases
por: Kamimiya, Hisashi, et al.
Publicado: (2013)